ID   M3K8_HUMAN              Reviewed;         467 AA.
AC   P41279; A8K2Q5; Q14275; Q5T855; Q9HC81;
DT   01-FEB-1995, integrated into UniProtKB/Swiss-Prot.
DT   19-JUL-2004, sequence version 2.
DT   05-OCT-2010, entry version 104.
DE   RecName: Full=Mitogen-activated protein kinase kinase kinase 8;
DE            EC=2.7.11.25;
DE   AltName: Full=Cancer Osaka thyroid oncogene;
DE   AltName: Full=Proto-oncogene c-Cot;
DE   AltName: Full=Serine/threonine-protein kinase cot;
DE   AltName: Full=Tumor progression locus 2;
DE            Short=TPL-2;
GN   Name=MAP3K8; Synonyms=COT, ESTF;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   MEDLINE=91304400; PubMed=2072910;
RA   Miyoshi J., Higashi T., Mukai H., Ohuchi T., Kakunaga T.;
RT   "Structure and transforming potential of the human cot oncogene
RT   encoding a putative protein kinase.";
RL   Mol. Cell. Biol. 11:4088-4096(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), AND SUBCELLULAR
RP   LOCATION.
RX   MEDLINE=94043034; PubMed=8226782;
RA   Aoki M., Sugimoto T., Sumida S., Hamada F., Akiyama T., Toyoshima K.;
RT   "The human cot proto-oncogene encodes two protein serine/threonine
RT   kinases with different transforming activities by alternative
RT   initiation of translation.";
RL   J. Biol. Chem. 268:22723-22732(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Bone;
RX   MEDLINE=93241735; PubMed=8479752;
RA   Chan A.M., Chedid M., McGovern E.S., Popescu N.C., Miki T.,
RA   Aaronson S.A.;
RT   "Expression cDNA cloning of a serine kinase transforming gene.";
RL   Oncogene 8:1329-1333(1993).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   SeattleSNPs variation discovery resource;
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-112.
RC   TISSUE=T-cell;
RX   MEDLINE=20469504; PubMed=10896655; DOI=10.1074/jbc.M000382200;
RA   Sanchez-Gongora E., Lisbona C., de Gregorio R., Ballester A.,
RA   Calvo V., Perez-Jurado L., Alemany S.;
RT   "COT kinase proto-oncogene expression in T cells: implication of the
RT   JNK/SAPK signal transduction pathway in COT promoter activation.";
RL   J. Biol. Chem. 275:31379-31386(2000).
RN   [10]
RP   ALTERNATIVE INITIATION, FUNCTION, SUBCELLULAR LOCATION, AND
RP   AUTOPHOSPHORYLATION.
RX   MEDLINE=92019818; PubMed=1833717;
RA   Aoki M., Akiyama T., Miyoshi J., Toyoshima K.;
RT   "Identification and characterization of protein products of the cot
RT   oncogene with serine kinase activity.";
RL   Oncogene 6:1515-1519(1991).
RN   [11]
RP   FUNCTION, AND INTERACTION WITH NFKB1 AND TNIP2.
RX   PubMed=15169888; DOI=10.1128/MCB.24.12.5235-5248.2004;
RA   Lang V., Symons A., Watton S.J., Janzen J., Soneji Y., Beinke S.,
RA   Howell S., Ley S.C.;
RT   "ABIN-2 forms a ternary complex with TPL-2 and NF-kappa B1 p105 and is
RT   essential for TPL-2 protein stability.";
RL   Mol. Cell. Biol. 24:5235-5248(2004).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-141, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
CC   -!- FUNCTION: Required for TLR4 activation of the MEK/ERK pathway.
CC       Able to activate NF-kappa-B 1 by stimulating proteasome-mediated
CC       proteolysis of NF-kappa-B 1/p105. Plays a role in the cell cycle.
CC       The longer form has some transforming activity, although it is
CC       much weaker than the activated cot oncoprotein.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR: Magnesium.
CC   -!- SUBUNIT: Forms a ternary complex with NFKB1 and TNIP2.
CC   -!- INTERACTION:
CC       P29678:MAP2K1 (xeno); NbExp=1; IntAct=EBI-354900, EBI-1631983;
CC       Q8NFZ5:TNIP2; NbExp=3; IntAct=EBI-354900, EBI-359372;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative initiation; Named isoforms=2;
CC       Name=1; Synonyms=58 kDa;
CC         IsoId=P41279-1; Sequence=Displayed;
CC       Name=2; Synonyms=52 kDa;
CC         IsoId=P41279-2; Sequence=VSP_018843;
CC   -!- TISSUE SPECIFICITY: Expressed in several normal tissues and human
CC       tumor-derived cell lines.
CC   -!- DEVELOPMENTAL STAGE: Isoform 1 is activated specifically during
CC       the S and G2/M phases of the cell cycle.
CC   -!- PTM: Autophosphorylated. Isoform 1 undergoes phosphorylation
CC       mainly on Ser residues, and isoform 2 on both Ser and Thr
CC       residues.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. STE Ser/Thr
CC       protein kinase family. MAP kinase kinase kinase subfamily.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- WEB RESOURCE: Name=SeattleSNPs;
CC       URL="http://pga.gs.washington.edu/data/map3k8/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D14497; BAA03387.1; -; mRNA.
DR   EMBL; Z14138; CAA78512.1; -; mRNA.
DR   EMBL; AK290320; BAF83009.1; -; mRNA.
DR   EMBL; AY309013; AAP45053.1; -; Genomic_DNA.
DR   EMBL; AL161651; CAI14227.1; -; Genomic_DNA.
DR   EMBL; CH471072; EAW86004.1; -; Genomic_DNA.
DR   EMBL; BC104833; AAI04834.1; -; mRNA.
DR   EMBL; BC113566; AAI13567.1; -; mRNA.
DR   EMBL; AF133211; AAG13454.1; -; Genomic_DNA.
DR   IPI; IPI00298726; -.
DR   IPI; IPI00759772; -.
DR   PIR; A48713; A48713.
DR   RefSeq; NP_005195.2; -.
DR   UniGene; Hs.432453; -.
DR   ProteinModelPortal; P41279; -.
DR   SMR; P41279; 116-385.
DR   DIP; DIP-27534N; -.
DR   IntAct; P41279; 40.
DR   MINT; MINT-1140505; -.
DR   STRING; P41279; -.
DR   PhosphoSite; P41279; -.
DR   PRIDE; P41279; -.
DR   Ensembl; ENST00000263056; ENSP00000263056; ENSG00000107968.
DR   Ensembl; ENST00000375321; ENSP00000364470; ENSG00000107968.
DR   Ensembl; ENST00000375328; ENSP00000364477; ENSG00000107968.
DR   GeneID; 1326; -.
DR   KEGG; hsa:1326; -.
DR   UCSC; uc001ivi.1; human.
DR   CTD; 1326; -.
DR   GeneCards; GC10P030762; -.
DR   H-InvDB; HIX0035411; -.
DR   HGNC; HGNC:6860; MAP3K8.
DR   HPA; CAB005120; -.
DR   HPA; HPA017962; -.
DR   MIM; 191195; gene.
DR   PharmGKB; PA30606; -.
DR   eggNOG; prNOG12247; -.
DR   HOGENOM; HBG717754; -.
DR   HOVERGEN; HBG006306; -.
DR   InParanoid; P41279; -.
DR   OMA; DCSPGMR; -.
DR   OrthoDB; EOG95B41S; -.
DR   PhylomeDB; P41279; -.
DR   BRENDA; 2.7.11.25; 247.
DR   Pathway_Interaction_DB; tcrjnkpathway; JNK signaling in the CD4+ TCR pathway.
DR   Pathway_Interaction_DB; tcrraspathway; Ras signaling in the CD4+ TCR pathway.
DR   Pathway_Interaction_DB; nfat_3pathway; Role of Calcineurin-dependent NFAT signaling in lymphocytes.
DR   Pathway_Interaction_DB; tcrpathway; TCR signaling in naive CD4+ T cells.
DR   Pathway_Interaction_DB; cd8tcrpathway; TCR signaling in naive CD8+ T cells.
DR   Reactome; REACT_6900; Signaling in Immune system.
DR   NextBio; 5403; -.
DR   ArrayExpress; P41279; -.
DR   Bgee; P41279; -.
DR   CleanEx; HS_MAP3K8; -.
DR   Genevestigator; P41279; -.
DR   GermOnline; ENSG00000107968; Homo sapiens.
DR   GO; GO:0005829; C:cytosol; EXP:Reactome.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0000287; F:magnesium ion binding; IEA:InterPro.
DR   GO; GO:0004709; F:MAP kinase kinase kinase activity; EXP:Reactome.
DR   GO; GO:0005515; F:protein binding; IPI:IntAct.
DR   GO; GO:0007049; P:cell cycle; IEA:InterPro.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; TAS:ProtInc.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR017424; MAPKKK8.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   PIRSF; PIRSF038171; MAPKKK8; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; FALSE_NEG.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Alternative initiation; ATP-binding; Complete proteome; Cytoplasm;
KW   Kinase; Magnesium; Metal-binding; Nucleotide-binding; Phosphoprotein;
KW   Polymorphism; Proto-oncogene; Serine/threonine-protein kinase;
KW   Transferase.
FT   CHAIN         1    467       Mitogen-activated protein kinase kinase
FT                                kinase 8.
FT                                /FTId=PRO_0000024350.
FT   DOMAIN      138    388       Protein kinase.
FT   NP_BIND     144    152       ATP (By similarity).
FT   ACT_SITE    253    253       Proton acceptor (By similarity).
FT   BINDING     167    167       ATP (By similarity).
FT   MOD_RES     141    141       Phosphoserine.
FT   VAR_SEQ       1     29       Missing (in isoform 2).
FT                                /FTId=VSP_018843.
FT   VARIANT     214    214       S -> F (in dbSNP:rs3087944).
FT                                /FTId=VAR_051638.
FT   VARIANT     398    415       CQSLDSALLERKRLLSRK -> GHQVIHEGSSTNDPNNSC
FT                                (in oncogenic form).
FT                                /FTId=VAR_006198.
FT   VARIANT     416    467       Missing (in oncogenic form).
FT                                /FTId=VAR_006199.
FT   CONFLICT    399    399       Q -> T (in Ref. 1; BAA03387 and 2).
SQ   SEQUENCE   467 AA;  52925 MW;  7728969EA3E4E8EC CRC64;
     MEYMSTGSDN KEEIDLLIKH LNVSDVIDIM ENLYASEEPA VYEPSLMTMC QDSNQNDERS
     KSLLLSGQEV PWLSSVRYGT VEDLLAFANH ISNTAKHFYG QRPQESGILL NMVITPQNGR
     YQIDSDVLLI PWKLTYRNIG SDFIPRGAFG KVYLAQDIKT KKRMACKLIP VDQFKPSDVE
     IQACFRHENI AELYGAVLWG ETVHLFMEAG EGGSVLEKLE SCGPMREFEI IWVTKHVLKG
     LDFLHSKKVI HHDIKPSNIV FMSTKAVLVD FGLSVQMTED VYFPKDLRGT EIYMSPEVIL
     CRGHSTKADI YSLGATLIHM QTGTPPWVKR YPRSAYPSYL YIIHKQAPPL EDIADDCSPG
     MRELIEASLE RNPNHRPRAA DLLKHEALNP PREDQPRCQS LDSALLERKR LLSRKELELP
     ENIADSSCTG STEESEMLKR QRSLYIDLGA LAGYFNLVRG PPTLEYG
//
